Adam H Schechter

Adam H. Schechter has been aDeVita director since September 2022. Mr. Schechter has served as Chairman of the Board of Laboratory Corporation of America Holdings, a clinical laboratory company (“LabCorp”), since May 2020, a director since April 2013, and as President and Chief Executive Officer of LabCorp since November 2019. Mr. Schechter previously served as special advisor to the Chief Executive Officer of Merck & Co., Inc., a multinational pharmaceutical company (“Merck”), from January 2019 to July 2019. Prior to that, Mr. Schechter was an Executive Vice President of Merck, where he was a member of Merck’s executive committee, pharmaceutical and vaccines operating committee, and President of Merck’s Global Human Health Division, which includes Merck’s worldwide pharmaceutical and vaccine businesses, from 2010 to 2018. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business of Merck from 2007 to 2010. He currently serves as a Board Member for Water.org and an executive board member for the National Alliance for Hispanic Health. In 2022, Mr. Schechter earned the CERT Certificate in Cybersecurity Oversight.